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It has been reported that American ginseng attenuates hyperglycemia and may present itself as
a supplement to diabetes therapy. However, the lack of standardization in the usage of ginseng
root leads to inconclusive results when applied to diabetes treatment. The mechanisms of
American ginseng root in the treatment of diabetes remains a mystery. This greatly limits the
effective utilization of American ginseng in facilitating diabetic therapy. Initiating studies have
shown that American ginseng increases insulin production and reduces cell death in pancreatic
b-cells. Also, studies have revealed American ginseng’s ability to decrease blood glucose in type
II diabetes patients as well as in streptozotocin-induced diabetic animals (STZ-diabetic mice).
These data suggest that effects of ginseng in improving hyperglycemia may alter mitochondrial
function as well as apoptosis cascades to ensure cell viability in pancreatic islet cells. This
review briefly summarizes current knowledge of ginseng components and clinical studies related
to diabetes. Further research will be needed to explore and identify the component(s) of
ginseng, which may be responsible for the beneficial effects observed in animal studies which
could then be extrapolated to human islets.
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Introduction
Due to a 3-fold increase in the consumption of herbal
remedies in the United States along with a staggering
popularity of the ginseng herb as a method of sustaining
good health, significant focus have been placed on two
widely used types of ginseng, American (Panax quinquefo-
lius L.) (1) and Asian ginseng (Panax ginseng CA Meyer)
(2–4). The usage of ginseng root for medicinal purposes
have been recorded for millennia, known as a tonic capable
ofsustaining longevity aswellasmaintainingviability(5,6).
The two species display different effects, possibly due to the
different active chemical makeup of each other. Asian
ginseng is said to facilitate blood flow, alleviate fatigue as
well as relieve oxidative stress in diabetic conditions
through various mechanisms such as the inhibition of
lipid peroxidation (7) (Table 1). American ginseng has been
reported to have stress-relieving qualities, anti-aging effects
and aids in digestion (3). Clinical studies have reported that
ginseng improves psychological function, immune function
and conditions associated with diabetes (8). Ginseng root
has been reported to treat diabetic symptoms in the Com-
pendium of Materia Medica (Ben Cao Gang Mu) by Dr Li
(Li, ShiZhen, Ming Dynasty from 1368 to 1644, in China).
This is the most complete and comprehensive pre-moderm
herbal textbook. The symptom was called Xiao Ke
described as over eating, drinking and losing energy, body
weight which are typical diabetic symptoms in modern
medicine. Common methods of treatment for hyper-
glycemia (high glucose) include both mono-therapy and
combination therapy with insulin, metformin, rosiglitazone
and acarbose. These treatments have been shown to help
control blood glucose levels but do not solve the problem–
no pancreatic b-cell function, which results in numerous
diabetic complications (9). Developmental information
shows American ginseng may correct hyperglycemia.
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properly cited.A Breakdown of Ginseng Components
A range of chemical components of ginseng such as
ginsenosides, alkaloids, polypeptides and polysaccharides
has been identified with their biological activity. The
elements Phosphorus (P), Potassium (K), Calcium (Ca),
Thallium (Ti), Manganese (Mn), Iron (Fe), Copper (Cu),
Zinc (Zn) and Strontium (Sr) were detected by screening
the components of ginseng (10). Other minor components
include volatile oils (member of vitamin B complex),
manganese, vanadium, copper, cobalt, fatty acids, amino
acids, simple sugars and other carbohydrates (11). Aside
from the basic elemental components of ginseng, glycosides
have been reported to be the active component in ginseng
responsible for ginseng’s medicinal value. Glycoside is a
naturally occurring substance consisting of a sugar and
non-sugar moiety. A group of saponins (glycoside which
produces froth by reducing water surface tension) in
ginseng were named ginsenosides, and were classified into
subclasses Ro, Ra, Rb, Rc, Rd, Re, Rf, Rg and Rh. These
ginsenosides were differentiated based on their retention
factor values in thin layer chromatography (TLC), which is
the distance that the ginsenosides travel up the TLC
column (12). More than 60 ginsenosides have been found in
different parts of the ginseng plant (13). Asian ginseng can
be distinguished from American using ginsenoside profiles
since Asian and American ginseng contains various gin-
senosides (14). A recent study analyzed the ginsenoside
composition of Asian and American ginseng through
observing 12 commercially available ginsenosides. Asian
ginseng contains ginsenoside Rf (15) and Rg2, but
American ginseng does not. Also, Rg1 content is over
10-folds as compared with American ginseng. However,
American ginseng contains twice the level of ginsenoside
Re. (16).
Since the usage of ginseng root extracts lacks stan-
dardization due to the different levels of ginsenosides in
different batches, purified ginsenosides have been used to
test whether the effects of ginseng root lies on one
ginsenoside or a combination of various ginsenosides.
The anti-hyperglycemic effects of the total ginsenosides
extracted from Asian ginseng were evaluated in diabetic
C57BL/6J ob/ob mice. Total ginsenosides had significant
anti-hyperglycemic and anti-obesity properties in a diabetic
ob/ob mouse model (17). In the same model, Ginsenoside
Re showed to improve muscle metabolism and reduce
inflammation through increase C-reactive protein levels,
leading to an anti-hyperglycemic effect (18). Ginsenoside
Rh2 was able to lower plasma glucose in STZ-diabetic rats
inadosagedependentmanner(19).Rh2hasalsobeennoted
to have the ability to regulate glucose by increasing insulin
secretion through the control of nerve terminals, signifying
that the effects of ginsenosides encompass the entire body
(20). There were no reports of ginsenosides affecting
pancreatic function in the mentioned studies. It is possible
that ginsenoside components create an anti-hyperglycemic
effect, which aids pancreatic function as well.
Ginseng Aids the Normalization
of Hyperglycemia
There have been numerous reports of ginseng root
(American and Asia ginseng) improving diabetic condi-
tions in both humans as well as animal studies. In animal
studies, orally administered ginseng root was able to
counteract the effects of high-fructose induced insulin
resistance in rats after 4 weeks, decreasing glucose concen-
trations, as well as inhibit insulin resistance (21). Ethanol
extract of ginseng root prevented weight gain, fasting blood
glucose, triglyceride and high free fatty acid levels in a high-
fat induced hyperglycemia mouse model (22). Ginsenoside
Re reduced blood glucose levels, cholesterol and triglycer-
ide levels as well as reduced oxidative stress in the eye
and kidney of diabetic rats (2). Clinical studies have
reported that American ginseng has the ability to lower
blood glucose in diabetic patients. (3) In some cases, both
type II diabetic patients and non-diabetic subjects showed
to benefit from an intake of American ginseng in terms of
stabilizing post-prandial glycemia after meals, suggesting
that the intake of ginseng may also benefit healthy
individuals. American ginseng did not have adverse effects
on healthy individuals but rather beneficial effects in post-
prandial glycemia compared with placebo when adminis-
tered together with the glucose challenge. In subjects with
type II diabetes mellitus, significant reductions were
observed when ginseng was taken 40min before the glucose
challenge (3). In both clinical and animal studies, ginseng
root has shown to have the ability to improve hypergly-
cemia in diabetic conditions.
Multiple Mechanisms Behind
the Effects of Ginseng
A limited amount of mechanism studies have been done on
the effects of American ginseng on either the pancreas or














Aids in digestion (rat) (43) Stimulates nervous system
(rat, cell) (2,44)
Reduces Stress (rat) (45) Anti-inflammatory agent
(cell) (46–48)
Enhances memory (rat) (49) Liver-protection (rat)(50)
Reduces cholesterol (cell) (5) Endurance (rat) (51)
Improves sexual function (rat) (52) Anti-Depression (mice) (53)
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which have been performed, ginseng root and components
seem to exert its effect through several different mecha-
nisms, suggesting that we have merely scraped the surface
in discovering the effects of ginseng and its components.
Studies have shown that ginseng and its components
attenuate hyperglycemia in two ways, the first through
enhancing pancreatic b-cell function and the other through
reducing insulin resistance. This leads us to believe that
ginseng may have benefits for both type I and type II
diabetes.
American ginseng root extracts have been shown to
affect pancreatic b-cells through altering cell metabolism,
increasing insulin production and reducing apoptosis in a
dosage dependent manner (23). Ginseng extracts were
able to enhance ATP production and in turn increase
insulin production, as insulin deficiency is often linked to
a lack of ATP produced (24,25). Along with an increase
in ATP production, ginseng reduced mitochondrial
protein UCP-2, which negatively regulates insulin secre-
tion (13,25–28). Aside from affecting insulin production,
ginseng may have the ability to target various glucose
receptors, creating an antilipolytic effect, thus attenuating
hyperglycemia (12,29). This suggests that there exist other
pathways through which ginseng acts through. Overall,
ginseng is able to enhance insulin production through
regulating cell metabolism.
Though UCP-2 regulates insulin secretion, it has also
been reported to decrease cell longevity (12,30). Apoptosis
is one of the common causes of cell death in pancreatic
b-cells. Resulting in the destruction of genetic material,
apoptosis is regulated by factors such as Bcl-2, which
protects against apoptosis and Caspase-3/9, which pro-
motes death through the caspase cascade (8,31,32).
American ginseng reduces apoptosis by promoting
caspase-3/9 and enhanced cell protective Bcl-2 protein
levels, resulting in protecting cells against apoptosis (23).
Preventing apoptosis allows for further cell function and
insulin production in pancreatic b-cells.
Aside from affecting cell metabolism and longevity,
ginseng has the ability to change neuropeptide through
Rh2, a ginsenoside derived from Panax ginseng, in
STZ-diabetic rats. Rh2 lowered plasma glucose due to
an increase in beta-endorphin secretion that activates
opioid mu-receptors thereby resulting in an increased
expression of GLUT 4, a glucose transporter in fat and
muscle tissue (19). Protopanaxatriol, a ginsenoside
metabolite, also increased GLUT4 and improved insulin
resistance (33). The up-regulation of GLUT-4 signalizes
that ginseng has an effect on fat/muscle tissue, possibly
decreasing insulin resistance.
Along with mechanisms pertaining to specific organs and
tissues, ginseng components have shown to have general
affects as well. Ginsenoside Re prevented oxidative stress
in (2) and reduce inflammation in STZ-diabetic rats (34).
In cellular models, ginseng reduces H2O2 induced
oxidative damage and enhances superoxide dismutase
and catalase to create a protective effect in a dosage
dependent manner (1). Ginseng leaf and berry extracts also
show high antioxidant activities which detoxify free
radicals excessively produced in diabetic environments
(35). Currently, studies show ginseng as having general
anti-oxidative properties in specific cells and tissue such as
pancreatic b-cells and fat/muscle tissue. We feel that there
are many more undiscovered mechanisms which ginseng
acts through.
Controversies Around the Benefits
of Ginseng on Diabetes
The usage of herbs and spices has long been documented
than modern pharmaceuticals. Unlike modern pharma-
ceuticals, which utilize small molecular weight com-
pounds consumed in a purified form, herbs are eaten in
combinations of unmeasured quantities. It is almost
certain the herbs contain beneficial qualities and that
the goal should not be to ask if they have effects but
rather what effects do they have (36). Since herbs have
been consumed in its natural form for the major duration
of history, very little attention has been paid to the
standardization in this industry. It could be possible that
the positive effects of ginseng on hyperglycemia may not
hold true for all ginseng products due to differences
in batches. Sievenpiper, Arnason et al discovered that
Asian ginseng showed both null and opposing effects on
indices of acute post-prandial plasma glucose and insulin,
which contrasted the findings with ginseng, thus showing
that different species attribute to different functions (3).
As with all chemical components, the metabolized form
could generate three possibilities: enhance activity,
become toxins, or have no effect. Currently, no studies
have taken this factor into consideration. Three main
concerns limiting the usage of ginseng include the
ubiquitous lack of standardization, in depth mechanism
studies, as well as widespread clinical studies (3).
Standardization of ginseng components would be the
first step to ensuring that there are no unnecessary
variations in the data.
Conclusion
It seems that ginseng and ginsenosides are beneficial for
diabetes therapy. Although single ginsenosides have shown
to have positive effects, whether a single component or a
mixture of components maximizes the therapeutic effect of
ginseng on diabetes is still unclear. Many steps have been
taken to standardize the usage of ginseng root through
isolating specific ginsenosides, which is an effective way to
maintain dosages and specificity. It is more than likely that
ginseng affects not only the pancreas to increase insulin
production but also other tissue to utilize insulin as well as
eCAM 2009;6(4) 425decrease insulin resistance through its various components
(15). Ginseng root has been shown to be effective in cell
cultures, animal studies, as well as clinical practice. Root
extracts and components exhibited anti-hyperglycemic
activities and reduced insulin resistance and increased
insulin production. Since the mechanisms behind ginseng’s
effects have not yet been fully discovered, we cannot
understand the full extent of its potential. Ginseng root is
able to increase insulin production and decrease cell
apoptosis in pancreatic b-cells, which signifies that ginseng
affects the pancreas directly. Also, ginseng has been shown
to mediate various mechanisms related to muscle and fat
tissue such as the GLUT4 pathway (see proposed mechan-
ism of ginseng’s activation in Fig. 1). Despite the lack of
sufficient widespread clinical, mechanistic studies and
standardization for immediate therapeutic uses greatly
hinders the possibility of practical applications, current
reports of ginseng and ginsenosides point to the possibility
of ginseng as a candidate for complementary diabetes
therapy.
Future Direction
In order to effectively apply ginseng on diabetes therapy,
three fronts must be expanded. First, standardization of
ginseng root has to be taken into consideration as different
batches contain different concentrations of ginsenosides.
Second, more clinical studies have to be performed to
confirm effects of ginseng on both type I and type II
diabetic patients. Third, the mechanisms behind ginseng’s
therapeutic effects have to be examined closely to see the
mechanisms which specific components of ginseng act
through. Taking these three routes into consideration,
the evident yet mysterious effects of ginseng could be
elucidated and applied to future therapies.
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Figure 1. The mechanisms of ginseng activation proposed here in
scheme summarizes that the active components of ginseng regulate
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and an increase of ATP production and thus insulin production, which
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also activates cytochrome-c related Bcl-2 expressing, leading to an
inhibition of caspase-9 triggered apoptosis cascade (23). ‘+’: positive
effects ‘-’: negative effects ‘solid-line arrow’: known actions ‘dotted-line
arrow’: recently discovered actions.
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